Learning from disease heterogeneity

The Lancet Oncology

Volumn 13, Issue 9, 2012, Pages 862-863

  Gaudet, Mia M ^a   Sherman, Mark E ^b   Thun, Michael J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADVANCED CANCER; CLEAR CELL OVARIAN CANCER; ENDOMETRIUM; ENDOMETRIUM CANCER; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MUCINOUS OVARIAN CANCER; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SEROUS OVARIAN CANCER; SMOKING; UTERINE TUBE;

ADENOCARCINOMA, MUCINOUS; FEMALE; HUMANS; OVARIAN NEOPLASMS; SMOKING;

EID: 84865553297     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70365-0     Document Type: Letter

References (11)

1. A review of human carcinogens: personal habits and indoor combustions in IARC Monographs on the evaluation of carcinogenic risks to humans 2012, vol. 100E. IARC, International Agency for Research on Cancer, Lyon.
2. Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol 2012, Collaborative Group on Epidemiological Studies of Ovarian Cancer, published online Aug 3. http://dx.doi.org/10.1016/S1470-2045(12)70322-4.
3. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet 2008, 371:303-314. Collaborative Group on Epidemiological Studies of Ovarian Cancer.
4. Werness BA, Ramus SJ, DiCioccio RA, et al. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int J Gynecol Pathol 2004, 23:29-34.
5. Kurman RJ, Shih Ie M The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010, 34:433-443.
6. Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012, 13:385-394.
7. Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008, 121:501-508. e3.
8. Hart WR Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms. Pathol Int 2005, 55:231-243.
9. Seidman JD, Kurman RJ, Ronnett BM Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003, 27:985-993.
10. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2009 2012, National Cancer Institute, Bethesda, MD.
11. Zaino RJ, Brady MF, Lele SM, Michael H, Greer B, Bookman MA Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study. Cancer 2011, 117:554-562.